COVID-19 associated pulmonary embolism: clinical, biochemical and CT imaging findings

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection represented a disruptive pathology that emerged in late 2019 with profound implications ranging from individual health to health systems and world economy. Our study aimed to evaluate clinical, biochemical and computerized tomography (CT) parameters values in determining the severity of pulmonary embolism (PE) associated with COVID-19.

Keywords

• pulmonary embolism
• thrombosis
• thromboinflammation
• covid-19
• sars-cov-2 infection
• risk factors